Works matching DE "VALSARTAN"

Results: 791

Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.

Published in:

2021

By:

Ruggenenti, Piero;
Cortinovis, Monica;
Parvanova, Aneliya;
Trillini, Matias;
Iliev, Ilian P.;
Bossi, Antonio C.;
Belviso, Antonio;
Aparicio, Maria C.;
Trevisan, Roberto;
Rota, Stefano;
Perna, Annalisa;
Peracchi, Tobia;
Rubis, Nadia;
Martinetti, Davide;
Prandini, Silvia;
Gaspari, Flavio;
Carrara, Fabiola;
De Cosmo, Salvatore;
Tonolo, Giancarlo;
Mangili, Ruggero

Publication type:

journal article

Impact of clinical pharmacy guidance on valsartan recall management: a retrospective review.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 278, doi. 10.1007/s40267-022-00918-6

By:

Sims, Kelli;
Zhu, Winnie;
Zaiken, Kathy

Publication type:

Article

Valsartan preconditioning protects against myocardial ischemia–reperfusion injury through TLR4/NF-κB signaling pathway.

Published in:

Molecular & Cellular Biochemistry, 2009, v. 330, n. 1/2, p. 39, doi. 10.1007/s11010-009-0098-1

By:

Jian Yang;
Hong Jiang;
Jun Yang;
Jia-Wang Ding;
Li-Hua Chen;
Song Li;
Xiao-Dong Zhang

Publication type:

Article

Acute Effects of Sacubitril/Valsartan with Initial Initiation in Pediatric Patients in the Cardiac Intensive Care Unit.

Published in:

Pediatric Cardiology, 2024, v. 45, n. 6, p. 1359, doi. 10.1007/s00246-023-03138-5

By:

Loomba, Rohit S.;
Ikeda, Nobuyuki;
Dorsey, Vincent;
Yousaf, Faeeq;
Nelson-McMillan, Kristen

Publication type:

Article

From Other Journals.

Published in:

Pediatric Cardiology, 2013, v. 34, n. 5, p. 1296, doi. 10.1007/s00246-013-0719-z

By:

Gandhi, Sanjiv;
Khalid, Omar

Publication type:

Article

Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1113, doi. 10.1007/s00228-024-03686-6

By:

Rindone, Joseph P.;
Mellen, Chadwick K.

Publication type:

Article

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1173, doi. 10.1007/s00228-023-03527-y

By:

Mapelli, Massimo;
Mattavelli, Irene;
Paolillo, Stefania;
Salvioni, Elisabetta;
Magrì, Damiano;
Galotta, Arianna;
De Martino, Fabiana;
Mantegazza, Valentina;
Vignati, Carlo;
Esposito, Immacolata;
Dell'Aversana, Simona;
Paolillo, Roberta;
Capovilla, Teresa;
Tamborini, Gloria;
Nepitella, Alessandro Alberto;
Filardi, Pasquale Perrone;
Agostoni, Piergiuseppe

Publication type:

Article

A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3

By:

Hedenmalm, Karin;
Quinten, Chantal;
Kurz, Xavier;
Bradley, Marie;
Lee, Hana;
Eworuke, Efe

Publication type:

Article

Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 663, doi. 10.1007/s00228-023-03484-6

By:

Luo, Hong-Yu;
Gao, Li-Chen;
Long, Hui-Zhi;
Zhou, Zi-Wei;
Xu, Shuo-Guo;
Li, Feng-Jiao;
Li, Hong-Li;
Cheng, Yan;
Li, Cai-Xia;
Peng, Xing-Yu;
Li, Liang;
Chen, Ran;
Deng, Ping

Publication type:

Article

Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 19, doi. 10.1007/s00228-021-03210-0

By:

Corrado, Egle;
Dattilo, Giuseppe;
Coppola, Giuseppe;
Morabito, Claudia;
Bonni, Enrico;
Zappia, Luca;
Novo, Giuseppina;
de Gregorio, Cesare

Publication type:

Article

Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1835, doi. 10.1007/s00228-021-03189-8

By:

Guerra, Federico;
Ammendola, Ernesto;
Ziacchi, Matteo;
Aspromonte, Vittorio;
Pellegrino, Pier Luigi;
Del Giorno, Giuseppe;
Dell'Era, Gabriele;
Pimpini, Lorenzo;
Santoro, Francesco;
Floris, Roberto;
Stronati, Giulia;
Nigro, Gerardo;
Paolisso, Pasquale;
Guido, Alessandro;
Maglia, Giampiero;
Brunetti, Natale Daniele;
Carbone, Angelo;
Gravellone, Miriam;
Antonicelli, Roberto;
Cannone, Michele

Publication type:

Article

A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 1, p. 125, doi. 10.1007/s00228-020-02979-w

By:

Norberg, Helena;
Bergdahl, Ellinor;
Ängerud, Karin Hellström;
Lindmark, Krister

Publication type:

Article

Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1121, doi. 10.1007/s00228-018-2509-2

By:

Schuehly, Uwe;
Ayalasomayajula, Surya;
Buchbjerg, Jeppe;
Pal, Parasar;
Golor, Georg;
Prescott, Margaret F.;
Sunkara, Gangadhar;
Hinder, Markus;
Langenickel, Thomas H.

Publication type:

Article

Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1021, doi. 10.1007/s00228-018-2477-6

By:

Pei, Qi;
Liu, Jun-Yan;
Yin, Ji-Ye;
Yang, Guo-Ping;
Liu, Shi-Kun;
Zheng, Yi;
Xie, Pan;
Guo, Cheng-Xian;
Luo, Mi;
Zhou, Hong-Hao;
Li, Xi;
Liu, Zhao-Qian

Publication type:

Article

Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey.

Published in:

2018

By:

Moulis, Florence;
Rousseau, Vanessa;
Chebane, Leila;
Gouverneur, Amandine;
Gaboriau, Louise;
Faillie, Jean-Luc;
Durrieu, Geneviève;
Montastruc, François;
Montastruc, Jean-Louis

Publication type:

Letter to the Editor

Recent major advances in cardiovascular pharmacotherapy.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 853, doi. 10.1007/s00228-018-2453-1

By:

Milner, James;
Cunha, Andreia;
Gamboa-Cruz, Carlota;
Reis, Julie;
Campos, Márcia;
António, Natália

Publication type:

Article

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 9, p. 1065, doi. 10.1007/s00228-016-2072-7

By:

Ayalasomayajula, Surya;
Langenickel, Thomas;
Jordaan, Pierre;
Zhou, Wei;
Chandra, Priyamvada;
Albrecht, Diego;
Pal, Parasar;
Rajman, Iris;
Sunkara, Gangadhar

Publication type:

Article

Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 917, doi. 10.1007/s00228-016-2062-9

By:

Langenickel, Thomas;
Jordaan, Pierre;
Petruck, Jesika;
Kode, Kiran;
Pal, Parasar;
Vaidya, Soniya;
Chandra, Priya;
Rajman, Iris

Publication type:

Article

Adsorption of a Mixture of Daily Use Pharmaceuticals on Pristine and Aged Polypropylene Microplastics.

Published in:

Environments (2076-3298), 2024, v. 11, n. 9, p. 198, doi. 10.3390/environments11090198

By:

Kalaronis, Dimitrios;
Evgenidou, Eleni;
Kyzas, George Z.;
Bikiaris, Dimitrios N.;
Lambropoulou, Dimitra A.

Publication type:

Article

HEART FAILURE: AN OVERALL ASSESSMENT.

Published in:

2023

By:

Vartela, Vasiliki

Publication type:

Editorial

Safety and Tolerability of Antihypertensive Agents in Long-term: A Literature Review.

Published in:

KnE Life Sciences, 2024, p. 196, doi. 10.18502/kls.v8i2.17372

By:

Veda Nugraha, Rhea;
Fahruzi, Odih;
Fajriyah, Siti Fajah

Publication type:

Article

Emperor-Preserved trial: what will change for patients with heart failure with preserved ejection fraction?

Published in:

2022

By:

Deaton, Christi

Publication type:

Editorial

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.

Published in:

NPJ Systems Biology & Applications, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41540-017-0013-4

By:

Iborra-Egea, Oriol;
Gálvez-Montón, Carolina;
Roura, Santiago;
Perea-Gil, Isaac;
Prat-Vidal, Cristina;
Soler-Botija, Carolina;
Bayes-Genis, Antoni

Publication type:

Article

The effects of valsartan treatment on visfatin levels and lipid profiles in newly diagnosed hypertensives.

Published in:

Turkish Journal of Medical Sciences, 2013, v. 43, n. 1, p. 57, doi. 10.3906/sag-1112-50

By:

ATACAN, İsmail;
PARLAK, Adem;
AYDOĞAN, Ümit;
SARI, Oktay;
GÖK, Deniz Engin;
ÇAYCI, Tuncer;
SAĞLAM, Kenan

Publication type:

Article

Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red.

Published in:

Pharmacia (0428-0296), 2021, v. 68, n. 4, p. 851, doi. 10.3897/pharmacia.68.e73559

By:

Peleshok, Kateryna;
Bondar, Bohdana;
Kryskiw, Liubomyr;
Kucher, Tetyana;
Poliak, Olha;
Logoyda, Liliya

Publication type:

Article

Search for angiotensin II receptor antagonists among 4-aryl-n-(aryl)-3-(prop-2-en-1-yl)-2,3- dihydro-1,3-thiazol-2-imine derivatives.

Published in:

Pharmacia (0428-0296), 2019, v. 66, n. 4, p. 181, doi. 10.3897/pharmacia.66.e36808

By:

Drapak, Iryna;
Zimenkovsky, Borys;
Perekhoda, Lina;
Suleyman, Margarita;
Yeromina, Hanna;
Skaletska, Natalia;
Seredynska, Natalya;
Demchenko, Anatoly

Publication type:

Article

Retraction Note: Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.

Published in:: 2024
Publication type:: Correction Notice

Knowledge domain and emerging trends in sacubitril/valsartan study from 2008 to 2023 -- a visualized conclusive analysis based on novel scientometric tools.

Published in:

European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 2, p. 502

By:

ZHAO, X.-C.;
HUANG, L.;
RONG, J.-C.;
LU, B.-H.

Publication type:

Article

Empagliflozin and sacubitril/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes – the role of morphology of mitochondria observed on electron microscopy.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 9, p. 3979

By:

DOGAN, Z.;
ERGUN, D. D.;
DURMUS, S.;
SAHIN, H.;
SENTURK, G. E.;
GELISGEN, R.;
SENYIGIT, A.;
UZUN, H.

Publication type:

Article

Clinical efficacy of enhanced external counter pulsation plus sacubitril/valsartan in the treatment of patients with chronic heart failure and the effect on ankle-arm index and cardiac function.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 8, p. 3300

By:

HUANG, X.-L.;
WANG, X.-J.;
CHEN, B.-T.;
CHEN, Y.-N.

Publication type:

Article

Author Correction: Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience.

Published in:: 2022
Publication type:: Correction Notice

Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience.

Published in:

European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 18, p. 5690

By:

MONZO, L.;
GAUDIO, C.;
CICOGNA, F.;
TOTA, C.;
PETRONILLI, V.;
MENNUNI, S.;
DE RUVO, E.;
CALÒ, L.

Publication type:

Article

Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII.

Published in:

European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 16, p. 5327

By:

BAO, S. L.;
PAN, J.;
SUN, H. X.;
LIU, W. T.

Publication type:

Article

Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.

Published in:

European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 5, p. 1159

By:

WANG, Z.-C.;
QI, J.;
LIU, L.-M.;
LI, J.;
XU, H.-Y.;
LIANG, B.;
LI, B.

Publication type:

Article

Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling.

Published in:

European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 2, p. 345

By:

ZHANG, M. -J.;
GU, Y.;
WANG, H.;
ZHU, P. -F.;
LIU, X. -Y.;
WU, J.

Publication type:

Article

Clinical study of double dose of valsartan combined with tacrolimus in treatment of diabetic nephropathy.

Published in:

European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 1, p. 174

By:

JIN, H.;
ZHANG, H.-N.;
HOU, X.-L.;
ZHANG, B.;
WU, J.;
ZHANG, H.-B.

Publication type:

Article

Photocatalytic Degradation of Valsartan by MoS 2 /BiOCl Heterojunctions.

Published in:

Catalysts (2073-4344), 2021, v. 11, n. 6, p. 650, doi. 10.3390/catal11060650

By:

Grilla, Eleni;
Kagialari, Maria Nefeli;
Petala, Athanasia;
Frontistis, Zacharias;
Mantzavinos, Dionissios

Publication type:

Article

Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 2, p. 119, doi. 10.1111/jcpt.12363

By:

Ansara, A. J.;
Kolanczyk, D. M.;
Koehler, J. M.

Publication type:

Article

Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 4, p. 452, doi. 10.1111/jcpt.12162

By:

Basile, G.;
Epifanio, A.;
Mandraffino, R.;
Trifirò, G.

Publication type:

Article

Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2009, v. 34, n. 6, p. 683, doi. 10.1111/j.1365-2710.2009.01053.x

By:

Miura, M.;
Satoh, S.;
Kagaya, H.;
Saito, M.;
Inoue, T.;
Ohkubo, T.;
Habuchi, T.;
Suzuki, T.

Publication type:

Article

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1177, doi. 10.1111/dom.13639

By:

Ruggenenti, Piero;
Trillini, Matias;
P. Barlovic, Drazenka;
Cortinovis, Monica;
Pisani, Antonio;
Parvanova, Aneliya;
Iliev, Ilian P.;
Ruggiero, Barbara;
Rota, Stefano;
Aparicio, Maria C.;
Perna, Annalisa;
Peraro, Francesco;
Diadei, Olimpia;
Gaspari, Flavio;
Carrara, Fabiola;
Stucchi, Nadia;
Martinetti, Davide;
Janez, Andrej;
Gregoric, Nadan;
Riccio, Eleonora

Publication type:

Article

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877

By:

Currie, Gemma;
Bethel, M. Angelyn;
Holzhauer, Björn;
Haffner, Steven M.;
Holman, Rury R.;
McMurray, John J. V.

Publication type:

Article

ARNI and SGLT2i: a promising association to be used with caution.

Published in:

2020

By:

Herbst, Andrea;
Orso, Francesco;
Migliorini, Marta;
Virciglio, Simona;
Tognelli, Silvia;
Camartini, Viola;
Pratesi, Alessandra;
Fattirolli, Francesco;
Marchionni, Niccolò;
Ungar, Andrea;
Baldasseroni, Samuele

Publication type:

Letter to the Editor

Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.

Published in:

Pediatric Nephrology, 2019, v. 34, n. 3, p. 495, doi. 10.1007/s00467-018-4114-0

By:

Lou-Meda, Randall;
Stiller, Brigitte;
Antonio, Zenaida L.;
Zielinska, Ewa;
Yap, Hui-Kim;
Kang, Hee Gyung;
Tan, Monique;
Glazer, Robert D.;
Valentin, Michele A.;
Wang, Linda

Publication type:

Article

Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 9, p. 2203, doi. 10.1185/03007995.2010.500883

By:

Joanne Chang;
Weiyi Yang;
Thomas Fellers;
Kristijan H. Kahler;
John Orloff;
Jipan Xie;
Magda Tsaneva;
Andrew P. Yu;
Eric Q. Wu

Publication type:

Article

Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 7, p. 1705, doi. 10.1185/03007995.2010.487391

By:

YuanNan Ke;
DingLiang Zhu;
HuaShan Hong;
JunRen Zhu;
RuoNan Wang;
Pamela Cardenas;
Ying Zhang

Publication type:

Article

Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 6, p. 1307, doi. 10.1185/03007991003711045

By:

Lesley-Ann Miller;
Rolin Wade;
Dingwei Dai;
Mark J. Cziraky;
Krishnan Ramaswamy;
Sumeet Panjabi

Publication type:

Article

Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 8, p. 1925, doi. 10.1185/03007995.2010.497326

By:

J. Heitmann;
T. Greulich;
C. Reinke;
U. Koehler;
C. Vogelmeier;
H.F. Becker;
A.C. Schmidt;
S. Canisius

Publication type:

Article

Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 12, p. 2933, doi. 10.1185/03007990903328231

By:

Francesco Locatelli;
Biff F. Palmer;
Naoki Kashihara;
Tevfik Ecder

Publication type:

Article

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 11, p. 2655, doi. 10.1185/03007990903251193

By:

H Schunkert;
R.D. Glazer;
M. Wernsing;
J. Yen;
C.E. Macarie;
M.M. Vintila;
J Romanova

Publication type:

Article